A carregar...

The Epothilones: New Therapeutic Agents for Castration-Resistant Prostate Cancer

The management of castration-resistant prostate cancer (CRPC) presents a clinical challenge because of limitations in efficacy and durability with currently available therapeutics. The epothilones represent a novel class of anticancer therapy that stabilizes microtubules, causing cell death and tumo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dorff, Tanya B., Gross, Mitchell E.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228074/
https://ncbi.nlm.nih.gov/pubmed/21964003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0014
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!